P53 levels determine outcome during β-catenin tumor initiation and metastasis in the mammary gland and male germ cells

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Oncogene

• Publication date

  2006-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1209391PMID 16434961
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The p53 pathway: positive and negative feedback loops

  2005cited by this paper
• Downregulation of β-catenin by p53 involves changes in the rate of β-catenin phosphorylation and Axin dynamics

  2004cited by this paper
• Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor

  2004cited by this paper
• Downregulation of beta-catenin by p53 involves changes in the rate of beta-catenin phosphorylation and Axin dynamics.

  2004cited by this paper
• Involvement of E‐cadherin and β‐catenin in germ cell tumours and in normal male fetal germ cell development

  2004cited by this paper
• A cytoskeleton-based functional genetic screen identifies Bcl-xL as an enhancer of metastasis, but not primary tumor growth

  2004cited by this paper
• Wnt Proteins in Mammary Development and Cancer

  2004cited by this paper
• To die or not to die: how does p53 decide?

  2004cited by this paper
• The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells

  2004cited by this paper
• Wnt Signaling and Mammary Tumorigenesis

  2004cited by this paper
• β‐Catenin and p53 analyses of a breast carcinoma tissue microarray

  2004influential reference
• Wnt proteins are lipid-modified and can act as stem cell growth factors

  2003cited by this paper
• Beta-catenin and Tcfs in mammary development and cancer.

  2003cited by this paper
• Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells

  2003cited by this paper
• Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis.

  2003influential reference
• β-Catenin and Tcfs in Mammary Development and Cancer

  2003cited by this paper
• Dissecting p53 tumor suppressor functions in vivo.

  2002cited by this paper
• Apc modulates embryonic stem-cell differentiation by controlling the dosage of β-catenin signaling

  2002cited by this paper
• β-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland

  2001influential reference
• Pin1 regulates turnover and subcellular localization of β-catenin by inhibiting its interaction with APC

  2001cited by this paper
• Down-regulation of beta-catenin by activated p53.

  2001cited by this paper
• Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis

  2001cited by this paper
• Δn89β-Catenin Induces Precocious Development, Differentiation, and Neoplasia in Mammary Gland

  2001cited by this paper
• Deregulated β‐catenin induces a p53‐ and ARF‐dependent growth arrest and cooperates with Ras in transformation

  2001influential reference
• Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein.

  2001cited by this paper
• Down-Regulation of β-Catenin by Activated p53

  2001cited by this paper
• Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses.

  2001cited by this paper
• Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC.

  2001cited by this paper
• β-Catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression

  2000cited by this paper
• Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression.

  2000cited by this paper
• Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.

  1999cited by this paper
• β-Catenin regulates expression of cyclin D1 in colon carcinoma cells

  1999cited by this paper
• Excess β‐catenin promotes accumulation of transcriptionally active p53

  1999cited by this paper
• Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.

  1998cited by this paper
• Retention of wild‐type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation

  1998cited by this paper
• IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools

  1998cited by this paper
• Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK‐3β and β‐catenin and promotes GSK‐3β‐dependent phosphorylation of β‐catenin

  1998cited by this paper
• Identification of c-MYC as a target of the APC pathway.

  1998cited by this paper
• Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta.

  1998cited by this paper
• Axin, a Negative Regulator of the Wnt Signaling Pathway, Directly Interacts with Adenomatous Polyposis Coli and Regulates the Stabilization of β-Catenin*

  1998cited by this paper
• p53-mediated germ cell quality control in spermatogenesis.

  1998cited by this paper
• An early and massive wave of germinal cell apoptosis is required for the development of functional spermatogenesis

  1997cited by this paper
• pangolinencodes a Lef-1 homologue that acts downstream of Armadillo to transduce the Wingless signal in Drosophila

  1997cited by this paper
• Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF.

  1997cited by this paper
• Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53

  1997cited by this paper
• XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos.

  1996cited by this paper
• Functional interaction of β-catenin with the transcription factor LEF-1

  1996cited by this paper
• Lessons from Hereditary Review Colorectal Cancer

  1996cited by this paper
• Functional interaction of beta-catenin with the transcription factor LEF-1.

  1996cited by this paper
• Effects of genetic background on tumorigenesis in p53‐deficient mice

  1995influential reference
• Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability.

  1995influential reference
• Genetic background alters the spectrum of tumors that develop in p53‐deficient mice

  1993cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992influential reference
• Endogenous mouse mammary tumor virus is expressed in several organs in addition to the lactating mammary gland

  1988cited by this paper
• Distribution of mouse mammary tumour virus antigens in RIII mice as detected by immunofluorescence on tissue sections and by immunoassays in sera and organ extracts.

  1980cited by this paper

• Development of a drug repressible β-catenin mutant mouse to examine effect of activated β-catenin signaling on long-term maintenance of mammary tumor growth

  2019cites this paper
• Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer.

  2018cites this paper
• p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors

  2017cites this paper
• MicroRNA-Mediated Post-Transcriptional Regulation of Epithelial to Mesenchymal Transition in Cancer

  2016cites this paper
• An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis.

  2016cites this paper
• Methods to Study Metastasis in Genetically Modified Mice.

  2016cites this paper
• Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73

  2015cites this paper
• Prolactin cooperates with loss of p53 to promote claudin-low mammary carcinomas

  2014cites this paper
• INTERACTION BETWEEN BRK AND HER2 IN BREAST CANCER

  2013cites this paper
• Etude des cellules souches et progénitrices mammaires et de leur contribution à la tumorigenèse : rôle des facteurs de transcription Myc et p53

  2012cites this paper
• p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2

  2011cites this paper
• Key signaling nodes in mammary gland development and cancer: β-catenin

  2010cites this paper
• Loss of heterozygosity of selected tumor suppressor genes in human testicular germ cell tumors.

  2010cites this paper
• Toll like receptor agonists: assessment of their potential in melanoma therapy

  2009cites this paper
• The search for cancer stem cells in hepatocellular carcinoma.

  2008cites this paper
• β-Catenin Expression Results in p53-Independent DNA Damage and Oncogene-Induced Senescence in Prelymphomagenic Thymocytes In Vivo

  2007cites this paper
• Mouse models of breast cancer metastasis

  2006cites this paper
• Cadherins and catenins in breast cancer.

  2005cites this paper